SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 171 filers reported holding SANGAMO THERAPEUTICS INC in Q1 2015. The put-call ratio across all filers is 0.04 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $9,475,014 | -54.1% | 15,796,956 | -0.6% | 0.00% | -100.0% |
| Q2 2023 | $20,655,669 | -25.9% | 15,888,976 | +0.3% | 0.00% | 0.0% |
| Q1 2023 | $27,879,621 | -42.2% | 15,840,694 | +3.1% | 0.00% | -50.0% |
| Q4 2022 | $48,228,644 | -31.0% | 15,359,441 | +7.7% | 0.00% | 0.0% |
| Q3 2022 | $69,894,000 | +36.5% | 14,264,458 | +15.4% | 0.00% | 0.0% |
| Q2 2022 | $51,196,000 | -24.1% | 12,366,166 | +6.5% | 0.00% | 0.0% |
| Q1 2022 | $67,485,000 | -22.8% | 11,615,096 | -0.4% | 0.00% | 0.0% |
| Q4 2021 | $87,472,000 | -14.0% | 11,662,880 | +3.3% | 0.00% | -33.3% |
| Q3 2021 | $101,725,000 | -13.1% | 11,290,265 | +15.4% | 0.00% | 0.0% |
| Q2 2021 | $117,113,000 | -4.5% | 9,783,968 | -0.0% | 0.00% | -25.0% |
| Q1 2021 | $122,644,000 | -17.8% | 9,788,014 | +2.3% | 0.00% | -20.0% |
| Q4 2020 | $149,283,000 | +59.7% | 9,566,415 | -3.3% | 0.01% | +66.7% |
| Q3 2020 | $93,478,000 | +0.8% | 9,891,873 | -4.4% | 0.00% | -25.0% |
| Q2 2020 | $92,696,000 | +55.2% | 10,345,516 | +10.3% | 0.00% | +33.3% |
| Q1 2020 | $59,735,000 | -25.1% | 9,377,336 | -1.6% | 0.00% | 0.0% |
| Q4 2019 | $79,800,000 | -8.1% | 9,534,271 | -0.6% | 0.00% | -25.0% |
| Q3 2019 | $86,847,000 | -14.5% | 9,596,401 | +1.7% | 0.00% | 0.0% |
| Q2 2019 | $101,584,000 | +27.8% | 9,432,178 | +13.2% | 0.00% | 0.0% |
| Q1 2019 | $79,508,000 | -17.9% | 8,334,148 | -1.1% | 0.00% | -20.0% |
| Q4 2018 | $96,785,000 | -31.4% | 8,430,838 | +1.3% | 0.01% | -16.7% |
| Q3 2018 | $141,063,000 | +22.9% | 8,322,311 | +3.0% | 0.01% | +20.0% |
| Q2 2018 | $114,780,000 | -9.7% | 8,083,121 | +20.8% | 0.01% | -16.7% |
| Q1 2018 | $127,150,000 | +12.8% | 6,692,054 | -2.6% | 0.01% | +20.0% |
| Q4 2017 | $112,691,000 | +11.6% | 6,871,509 | +2.1% | 0.01% | 0.0% |
| Q3 2017 | $100,997,000 | +104.1% | 6,733,161 | +19.7% | 0.01% | +66.7% |
| Q2 2017 | $49,496,000 | +69.4% | 5,624,563 | +0.1% | 0.00% | +50.0% |
| Q1 2017 | $29,217,000 | +182506.2% | 5,618,851 | +107458.4% | 0.00% | – |
| Q4 2016 | $16,000 | -44.8% | 5,224 | -12.9% | 0.00% | – |
| Q3 2016 | $29,000 | -25.6% | 5,997 | -11.8% | 0.00% | – |
| Q2 2016 | $39,000 | -11.4% | 6,797 | -6.2% | 0.00% | – |
| Q1 2016 | $44,000 | +144.4% | 7,244 | +268.7% | 0.00% | – |
| Q4 2015 | $18,000 | +63.6% | 1,965 | 0.0% | 0.00% | – |
| Q3 2015 | $11,000 | -50.0% | 1,965 | 0.0% | 0.00% | – |
| Q2 2015 | $22,000 | -33.3% | 1,965 | -5.0% | 0.00% | – |
| Q1 2015 | $33,000 | +6.5% | 2,068 | 0.0% | 0.00% | – |
| Q4 2014 | $31,000 | +40.9% | 2,068 | 0.0% | 0.00% | – |
| Q3 2014 | $22,000 | -29.0% | 2,068 | 0.0% | 0.00% | – |
| Q2 2014 | $31,000 | +6.9% | 2,068 | +27.4% | 0.00% | – |
| Q1 2014 | $29,000 | +38.1% | 1,623 | +9.4% | 0.00% | – |
| Q4 2013 | $21,000 | +50.0% | 1,483 | +8.8% | 0.00% | – |
| Q3 2013 | $14,000 | +27.3% | 1,363 | 0.0% | 0.00% | – |
| Q2 2013 | $11,000 | – | 1,363 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Golden State Equity Partners | 154,360 | $897,000 | 0.45% |
| Rhenman & Partners Asset Management AB | 761,429 | $4,424,000 | 0.44% |
| Lombard Odier Asset Management (Switzerland) SA | 860,702 | $5,001,000 | 0.39% |
| WASATCH ADVISORS LP | 10,576,997 | $61,452,000 | 0.30% |
| Rokos Capital Management LLP | 977,663 | $5,861,000 | 0.27% |
| KLK CAPITAL MANAGEMENT LLC | 44,323 | $258,000 | 0.26% |
| Long Focus Capital Management, LLC | 340,000 | $1,975,000 | 0.25% |
| Vanguard Capital Wealth Advisors | 33,380 | $193,000 | 0.14% |
| Fort Sheridan Advisors LLC | 73,978 | $430,000 | 0.13% |
| Delphia (USA) Inc. | 20,983 | $122,000 | 0.09% |